kezar life sciences share price

Kezar Life Sciences Inc is a clinical-stage biotechnology company. Kezar Life Sciences KZR stock price revenue and financials.

Kezar Life Sciences Prepares For U S Ipo Nasdaq Kzr Seeking Alpha

In terms of relative price strength the Kezar Life Sciences share price has outperformed the SP500 Index by 10282 over the past year.

. KZR announced topline results from the PRESIDIO Phase 2 trial of zetomipzomib KZR-616 in patients with dermatomyositis DM and polymyositis PM chronic. Shares of Kezar Life Sciences Inc. Tumbled in premarket trading Wednesday after the clinical-stage biotechnology company reported disappointing Phase 2 study results for zetomipzomib its lead.

Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus Nephritis. 3 equities research analysts have issued 12-month price targets for Kezar Life Sciences stock. The average Kezar Life Sciences stock price for the last 52 weeks is 987.

Kezar Appoints Courtney Wallace to its Board of Directors. Kezar Life Sciences to Participate in Cowen 42nd Annual Health Care Conference. No significant news for KZR in the past two years.

On average they anticipate Kezar Life Sciences share price to reach 1833 in the next year. Their forecasts range from 1400 to 2200. 7 hours agoKezar Life Sciences Inc NASDAQ.

57 of Cytokinetics shares are owned by insiders. This suggests a possible upside of 520 from the stocks current price. Kezar Life Sciences market cap is 7235 m.

Kezar Life Sciences Inc stocks price quote with latest real-time prices charts financials latest news technical analysis and opinions. Do institutionals and insiders hold more shares of CYTK or KZR. 5 hours agoKezar Life Sciences Inc NASDAQKZR shares are trading lower by 3823 at 761 after the company announced top-line results from its PRESIDIO Phase 2 clinical trial of Zetomipzomib.

Over the past year the SP 500 is down -005 while KZR has risen 3322. 8 hours agoOn average analysts expect that Infinera will post -008 earnings per share for the current year. That KEZAR LIFE SCIENCESs share price could reach 2050 by Mar 18 2023.

Is a clinical-stage biopharmaceutical company that is focused on discovering and developing. On average Wall Street analysts predict. Kezar Life Sciences NASDAQKZR Price Target Lowered.

Summary of all time highs changes and price drops for Kezar Life Sciences. KZR lost -104 per share in the over the last 12 months. Kezar Life Sciences NASDAQKZR Price Target Lowered to 1400.

Director Thomas Woiwode reported the purchase of 212 million shares at 236share. A financial ratio used to compare a companys current market price to its book value. The Kezar Life Sciences 52-week low stock price is 461 which is 692 below the current share price.

8 hours agoThe ride-sharing company reported 007 earnings per share for the quarter beating analysts consensus estimates of 007 by 014. The Kezar Life Sciences 52-week high stock price is 1855 which is 237 above the current share price. Kezar Life Sciences Inc NASDAQ.

KZR is down -466 from the previous closing price of 1232 on volume of 1520668 shares. Comparatively Kezar Life Sciences has a beta of 027 indicating that its share price is 73 less volatile than the SP 500. View the latest Kezar Life Sciences Inc.

PFE Price Target to 5500. Shares in Kezar Life Sciences last closed at 1210 and the price had moved by 10648 over the past 365 days. The all-time high Kezar Life Sciences stock closing price was 3290 on December 13 2018.

Kezar Life Sciences Inc. KZR stock price news historical charts analyst ratings and financial information from WSJ. KZR shares are trading lower by 3823 at 761 after the company announced top-line results from its PRESIDIO Phase 2 clinical trial of ZetomipzomibKezar Life Sciences says most patients saw clinically meaningful improvements in the primary endpoint measure of Total Improvement Score TIS but no differentiation from.

Kezar Life Sciences Inc NASDAQ. 638 of Kezar Life Sciences shares are owned by institutional investors. Kezar Life Sciences Inc KZR stock has fallen -3782 while the SP 500 is down -031 as of 1054 AM on Wednesday May 4.

Kezar Life Sciences Inc. Dow Jones Gold Price Oil Price EURO DOLLAR CAD USD PESO USD POUND USD. 8 hours agoHC Wainwright lifted their target price on Kezar Life Sciences from 2000 to 2200 and gave the stock a buy rating in a report on.

Latest closing price divided by the last 12 months revenuecash flow per share. The average KEZAR LIFE SCIENCES stock price prediction forecasts a potential upside of 2531 from the current KZR share price of 1636. The average KEZAR LIFE SCIENCES stock price prediction forecasts a potential upside of 2531 from the current KZR share price of 1636.

The all-time high Kezar Life Sciences stock closing price was 3290 on December 13 2018. Price To Cash Flow Per Share TTM Total DebtTotal Equity Quarterly.

Kzr Stock Climbs On Insider Purchase Nasdaq Kzr Seeking Alpha